AlphAIalphai — Financial news for AI agents
finanznachrichten.deAUG 186 min read$PRE

Prenetics Global Limited: Prenetics' IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220-230 Million; July Was the First Month of Positive Consolidated Adjusted

Prenetics Global (NASDAQ: PRE) reported Q2 2026 revenue of $46.5 million, up about 288% YoY, and IM8 revenue of $45.0 million, up about 359% YoY. Results were within guidance. The company raised FY 2026 total revenue guidance to $220-230 million and initiated FY 2027 IM8 revenue guidance of $400 million+.

Original reporting
finanznachrichten.de
Published Aug 18, 2026, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 12:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$PRE
Bullish
high confidence
Mentioned
$PRE
Relevance
9/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$PREBullishHigh
01

Why it matters

The key trading driver is the combination of Q2 outperformance versus guidance ranges and a raised FY2026 revenue outlook, plus initiation of FY2027 IM8 revenue guidance at $400M+.

02

Market read

A same-day earnings release with explicit guidance raises and new FY2027 IM8 revenue targets is likely to drive estimate revisions and near-term positioning in PRE.

03

What to watch

The release notes a Customer Investment Agreement with GC Customer Value Arranger, LLC and other forward-looking risks; traders may scrutinize whether financing or customer investment dynamics are supporting growth.

Relevance 9/10Novelty 9/10Timing: today at 8:30 a.m. ET earnings webcast following Q2 results and guidance raise

Background

Prenetics’ IM8 is positioned as an AI-native direct-to-consumer wellness brand; this quarter marks a shift to more detailed shareholder materials and a live earnings stream.

Company-level read

Ticker impact

$PREBullishHigh confidence
Context

Prenetics reported Q2 2026 revenue of $46.5M (+288% YoY) and raised FY 2026 total revenue guidance to $220-$230M.

Expected impact

Likely positive reaction and higher probability of upward estimate revisions, especially if investors focus on the new FY2026 and FY2027 IM8 guidance.

Evidence & confidence

The article discloses fresh, decision-relevant datapoints: Q2 results, raised FY2026 guidance, and initiated FY2027 IM8 revenue guidance of $400M+.

Market effects

Sector

Consumer health and DTC wellness investors may re-rate growth expectations for AI-native supplement brands if PRE’s cohort economics and card data support durability.

Regional

Limited, primarily US small/mid-cap growth sentiment tied to NASDAQ-listed PRE.

Global

Moderate, as PRE highlights IM8 shipping to 46 countries and global run-rate momentum.

Counterpoint

What could challenge this read

The guidance jump could be driven by early-stage scale effects; investors may discount sustainability until cohort economics and third-party card data confirm retention and CAC efficiency.

Key entities

  • company
    Prenetics Global Limited

    NASDAQ-listed parent of IM8 that reported Q2 2026 results and raised FY2026 guidance.

  • brand
    IM8

    Prenetics’ direct-to-consumer wellness brand; reported IM8 revenue growth and provided run-rate momentum.

  • person
    Danny Yeung

    CEO and co-founder of IM8, quoted on record quarter, positive consolidated adjusted free cash flow, and guidance changes.

Read at source← All news

Related articles

JUL 30
$PREMed

PartnerRe records $447m in first-half net income

PartnerRe reported first-half 2026 net income of $447 million, down from $493 million a year earlier, with operating income of $689 million and annualised operating ROE of 12.6%. Gross premiums written rose to $5.42 billion. Non-life underwriting profit was $396 million with a 85.1% combined ratio. Investment income increased to $491 million, but unrealised losses reduced net investment return.

royalgazette.com4 min
AUG 18
$HDMed

What Home Depot’s earnings beat means for peer Lowe’s stock

Investing.com says Home Depot’s Q2 results beat expectations, with revenue of $47.86B and EPS of $4.92 versus $4.73 expected. The article links HD’s maintained full-year guidance (flat to +2% comparable sales, flat to +4% adjusted EPS) to expectations for Lowe’s upcoming report, highlighting Lowe’s higher exposure to lawn and garden and appliances. Options imply a ~3.9% move.

investing.com6 min
AUG 18
$HDMedAI 8/10

Home Depot sales lifted by customers focusing on smaller projects

Home Depot reported Q2 revenue of $47.86B, up from $45.28B and above FactSet’s $47.24B estimate. Comparable store sales rose 1.7% globally and 1.3% in the U.S. Earnings were $4.77B, or $4.79/share, versus $4.73/share expected; guidance for 2026 and comps was unchanged. The company also plans nationwide express delivery within three hours.

abcnews.com3 min
Prenetics Global Limited: Prenetics' IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220-230 Million; July Was the First Month of Positive Consolidated Adjusted — alphai